Legacy App users can now access the Health Portal – just reset your password using email as username.

Elevated PSA – What To Do

Elevated PSA – What To Do

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:18
The video introduces PSA testing and explains why elevations are common and nonspecific. A calm, structured response is encouraged.
02:42
Benign causes of PSA elevation such as BPH and prostatitis are reviewed. Contributors outside of cancer are emphasized.
05:18
The importance of PSA trends and repeat testing is discussed. Single values are placed in context.
07:51
Risk stratification tools and next diagnostic steps, including imaging, are outlined. Avoiding unnecessary procedures is highlighted.
10:52
The closing segment focuses on shared decision-making and individualized care. Anxiety reduction and appropriate follow-up are emphasized.

Video Summary

Prostate-specific antigen (PSA) is a blood marker produced by prostate tissue and commonly used in prostate health screening. An elevated PSA does not automatically indicate prostate cancer, as levels can rise due to benign prostatic hyperplasia, prostatitis, recent ejaculation, or medical procedures. The video emphasizes avoiding panic and instead taking a structured approach.

Evaluation of an elevated PSA begins with confirming the result and reviewing contributing factors such as infections, medications, urinary symptoms, and recent activities. PSA trends over time are often more informative than a single value. The discussion highlights the importance of repeat testing, free PSA, and risk stratification before invasive steps.

Management decisions may include observation, further blood tests, imaging such as prostate MRI, or referral to urology when appropriate. The goal is to identify clinically significant disease while minimizing unnecessary biopsies and anxiety. Shared decision-making and individualized risk assessment are central themes.

Drug Callouts

Drug
Description
5-alpha reductase inhibitors
5-alpha reductase inhibitors are medications that reduce prostate size and lower PSA levels over time. PSA interpretation must account for their use.

Condition Callouts

Condition
Description
Elevated PSA
Elevated PSA refers to higher-than-expected prostate-specific antigen levels in the blood. It requires contextual interpretation rather than immediate alarm.
Benign prostatic hyperplasia
Benign prostatic hyperplasia is noncancerous enlargement of the prostate that commonly raises PSA levels. It is a frequent cause of PSA elevation.
Prostatitis
Prostatitis is inflammation or infection of the prostate that can acutely raise PSA. Treating inflammation often normalizes levels.
Prostate cancer
Prostate cancer is a malignant growth of prostate tissue. PSA is a screening tool but not a definitive diagnostic test.
Lower urinary tract symptoms
Lower urinary tract symptoms include frequency, urgency, weak stream, and nocturia. These symptoms often coexist with PSA elevation.

Key Takeaways

  • An elevated PSA does not automatically mean prostate cancer.
  • Benign conditions commonly raise PSA levels.
  • PSA trends over time provide more insight than a single test.
  • Stepwise evaluation reduces unnecessary biopsies.
  • Shared decision-making improves outcomes and reduces anxiety.

More Videos